Drive Smarter Oncology Development with AI and RWE

Connect with Our Experts

Oncology has always led the way in clinical innovation. Now, artificial intelligence (AI) and real-world evidence (RWE) are transforming the way trials are designed, executed, and evaluated—bringing new opportunities and new regulatory considerations.

Our experts will guide you toward success. We can help you:

  • Navigate evolving regulations: Understand FDA initiatives, global guidance, and regulatory expectations for AI and RWE in oncology development.
  • Apply AI and RWE across the trial lifecycle: Enhance diagnostic accuracy, streamline recruitment, and enable more personalized medicine.
  • Improve trial efficiency and outcomes: Leverage data-driven approaches to accelerate timelines, reduce risk, and support smarter decisions.
  • Adapt to future trends: Prepare for a landscape where AI-enabled and RWE-supported trials will be increasingly standard.
  • Strengthen post-marketing surveillance: Use AI and RWE to generate insights that extend beyond approval into real-world patient impact.

Meet our Experts


Meera Belur – Executive Director, Oncology Program Strategy

Cathy Gatza, PhD – Vice President, Regulatory Strategy

 

Ready to get started?

Complete the form to schedule an informational session with our expert

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Premier Research that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.